A recent clinical trial found that a new TROP2-targeted antibody-drug conjugate (ADC) showed encouraging efficacy in treating ...

The upcoming American Society of Hematology (ASH) 2025 meeting is poised to spotlight several pivotal developments across ...

Antonio Urbina, MD, the medical director for the Mount Sinai Institute for Advanced Medicine 7th Avenue clinic in New York ...

Panelists discuss how PCSK9 inhibitors remain underused due to access, cost, and adherence barriers.

The decision to use newer agents in relapsed/refractory follicular lymphoma is heavily influenced by the disease’s inherent ...

Quality improvement programs markedly increase sleep apnea testing in stroke patients, showing effective ways to improve guideline-based care.

Adding lumateperone (Caplyta; Johnson & Johnson) to ongoing antidepressant therapy (ADT) significantly improved depression severity in adults with major depressive disorder (MDD) who had not responded ...

Experts explain that DTC models could improve medication adherence through convenience and incentives, but higher costs may limit their effectiveness.

Here are 5 things driving dental health care access in underserved communities.

Other abstracts will offer data on bispecifics moving into frontline therapy; examples include data coming Saturday from EPCORE-NHL2 involving epcoritamab in diffuse large B-cell lymphoma, and the ...

Clinicians treating follicular lymphoma face a critical sequencing concern: whether prior CD19-directed therapies cause the loss or downregulation of the CD19 antigen, which is required for effective ...

Minimally invasive treatment and earlier surgical consideration for thymectomy led the way as potential treatments for ...